The Biocidal Products Regulation (Reg. (EU) no. 528/2012 or BPR) concerns issuing on the market and the use of all products that, thanks to the specific properties of the substances they contain (active ingredients) are used to protect humans, animals, materials or objects of common use from the action of harmful organisms, such as parasites or bacteria.
The BPR came into force on September 1, 2013 and the previous regulatory framework on biocidal products should be understood as repealed from that date (Dir. 98/8/EC).
With the implementation of the BPR, a general system for biocidal product management is set up, harmonised throughout the European Union. As a matter of fact, the BPR not only establishes detailed provisions on how to conduct the scientific assessment of the risks associated to active principles and to biocidal products, but provides all companies with specific information on how to obtain from the competent authorities the required authorisations to be able to place on the market a biocidal product in any country belonging to the European Union.
The BPR also promotes the reduction of animal experimentation, introducing obligations concerning the sharing of data and fostering the use of alternative experimentation methods.